Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (5908)	10/11/1998 11:29:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

Vienna: Pfizer Austria holds a series of seminars on the safety and effectiveness of its new anti-impotence drug Viagra and the drug's economic performance. 9:30 a.m. Vienna Stock Exchange. Sunday, Oct. 18. (See: PFE US CN) news.com

To: Anthony Wong who wrote (5908)	10/12/1998 9:02:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Weak rouble delays Viagra introduction Monday October 12 4:50 PM EDT MOSCOW (Reuters) - Impotent Russian men will have to endure another month before the introduction of the drug Viagra because of the country's flaccid currency, a top Pfizer official said on Monday. Pfizer had announced it would bring in the much-publicized impotence drug to Russia by October. But the collapse of the rouble in August made foreign medicine much more expensive and imports of all drugs have fallen sharply since then. ''We decided that because of all the changes and particularly because of the difficulties being experienced in a lot of the distributors here in Russia to put the launch back to the beginning of November,'' said Robert Marshall, head of the Russia office for the U.S. drugs firm Pfizer which makes Viagra. Experts say Russian men suffer from the same sexual problems as males in other nations and so the country of 150 million has a large potential market. But many may be frustrated by the high cost after the rouble's devaluation. ''For sure, we suspect we will sell a little bit less than we would have done before,'' Marshall told Reuters. The drug will initially be available in major Russian cities, but may be hard to find east of Novosibirsk in Siberia, Marshall said. dailynews.yahoo.com